Zestmab 500 mg Injection
$448,89
$350,14
Zestmab 500 mg injection is a powerful monoclonal antibody designed to address various immune-related conditions, playing a vital role in the management of specific cancers such as non-Hodgkin's lymphoma and chronic lymphocytic leukemia. By targeting and binding to specific proteins on the surface of cancer cells, Zestmab helps to inhibit tumor growth and promote the body's immune response against malignant cells. This targeted therapy not only enhances treatment efficacy but also minimizes damage to healthy tissues compared to traditional chemotherapy options. Patients should be aware of potential side effects, which can include infusion reactions and increased susceptibility to infections, necessitating close monitoring during treatment. It’s important to discuss your medical history with your healthcare provider to ensure the safety and effectiveness of Zestmab for your condition. As with any medication, proper administration and adherence to prescribed dosages are crucial for optimal results. Overall, Zestmab represents a significant advancement in cancer treatment, offering hope to those battling these challenging diseases. With ongoing research, the potential applications of Zestmab may expand, further enhancing its role in modern oncology.
數量
Active Pharmaceutical Ingredient
Uses
• Zestmab 500 mg injection is primarily used in the treatment of Non-Hodgkin lymphoma (NHL). This medication helps target specific cells involved in the cancer, aiming to reduce tumor size and improve patient outcomes. Patients receiving Zestmab may experience a decrease in the progression of the disease. It is often administered as part of a broader treatment regimen.
• Another significant use of Zestmab 500 mg injection is in managing rheumatoid arthritis. This condition causes inflammation and pain in the joints, and Zestmab works by modulating the immune response. By doing so, it can help alleviate symptoms and improve joint function. Patients often notice a reduction in flare-ups when treated with this injection.
• Zestmab 500 mg injection is also effective in treating chronic lymphocytic leukaemia, a type of blood cancer. This medication acts on the malignant cells, helping to control the proliferation of these cells in the bloodstream. By utilizing Zestmab, healthcare providers aim to enhance the quality of life for patients dealing with this condition. Regular monitoring and follow-up are essential during treatment.
• Additionally, Zestmab 500 mg injection is utilized in treating granulomatosis with polyangiitis and microscopic polyangiitis. These rare autoimmune conditions lead to inflammation of blood vessels, which can result in various organ damage. Zestmab helps to reduce this inflammation, promoting better organ function and overall health. Patients receiving this injection often report improved stability of their condition over time.
Benefits
Non-Hodgkin lymphoma (NHL): Non-Hodgkin's lymphoma is a form of cancer that affects the white blood cells in the body. These cells are responsible for preventing infections. Zestmab 500 mg Injection has been demonstrated to reduce the immune response and relieve pain and inflammation. It also can kill cancer cells and prevent their further growth. To prevent the spread of infection, it is advisable to avoid crowds and to wash your hands frequently. It is recommended that patients consume an adequate quantity of fluids unless otherwise advised by their physician. Rheumatoid arthritis: Zestmab 500 mg is an immunosuppressant that is used to treat rheumatoid arthritis. It is administered in a dose and frequency that is tailored to the patient's condition. This is determined by the physician. It is crucial to adhere to the physician's instructions and to promptly report any adverse effects, including fever, chills, or other symptoms, to the physician. Blood cancer (Chronic lymphocytic leukaemia): Leukaemia, also known as blood cancer, is a malignant neoplasm of the haematopoietic tissues that impairs the body's ability to combat infection. Zestmab 500 Injection is a chemotherapeutic agent that kills or inhibits the proliferation of malignant cells and is effective in the treatment of leukaemia. However, it is important to discuss the potential side effects and benefits of this medication with a qualified healthcare professional. It is also essential to inform your doctor of any adverse effects that may arise during treatment. Granulomatosis with polyangiitis: Granulomatosis with polyangiitis (GPA) is a condition that causes inflammation of the blood vessels of the ears, nose, throat, lungs, and kidneys. In this condition, the blood flow to these areas may be reduced, which can lead to their damage. Zestmab 500 mg Injection is an effective treatment that helps reduce inflammation, pain, and swelling and prevents further damage. This improves the quality of life of those affected by GPA. Microscopic polyangiitis: Microscopic polyangiitis is an autoimmune disease that affects the small blood vessels and may be caused by an imbalance in the immune system. Zestmab 500 Injection reduces the immune response and improves inflammation. This helps to heal the condition and to alleviate discomfort.
Side Effects
Zestmab 500 mg Injection can cause various adverse effects that can differ from one person to another. Some of the adverse effects of the drug are listed below.
Most Common Side Effects
• Low Immunity
• Nausea
• Tinnitus
• Muscle Pain and Stiffness
• Face Swelling
• Low Blood Count of White Blood Cells and Red Blood Cells
• Increase in Glucose Levels in Blood
• Headache
Common Side Effects
• Skin Reactions
• Heart Problems
• Infections
• Allergies
How To Use
The administration of Zestmab 500 mg Injection is typically conducted by a medical professional, such as a doctor or nurse, in a medical facility, such as a hospital or clinic. It is not advisable to administer the product independently, and it is important to adhere to the instructions provided by a qualified healthcare professional.
Safety Advice
• Alcohol: Caution should be exercised when drinking alcohol with Zestmab 500 mg. Please consult your doctor.
• Kidney: Zestmab 500 Injection is likely to be safe in patients with kidney disease. The limited data available suggest that dose adjustment of Vortuxi Solution for Infusion may not be necessary for these patients. Please consult your doctor.
• Breastfeeding: Zestmab 500 mg Injection is likely to be safe to use while breast-feeding, and limited human statistics support that the drug now no longer poses a good risk to the baby.
• Liver: Zestmab 500 mg Injection is not recommended in patients with active liver disease or those who have had viral hepatitis. Please consult your doctor.
• Pregnancy: Zestmab 500 mg Injection may not be safe for use during pregnancy. Although there is limited human research, animal research has shown dangerous effects on the growing baby. Your doctor will weigh up the benefits and potential risks before prescribing it to you. Please consult your doctor.
• Driving: It is not known whether Zestmab 500 mg affects your ability to drive. Do not drive if you experience symptoms that affect your ability to concentrate and react.